Printer Friendly
The Free Library
5,673,733 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Elekta Receives Judgment From First Instance in Patent Dispute.


Business Editors, Health/Medical Writers

STOCKHOLM, Sweden--(BUSINESS WIRE)--Sept. 12, 2002

As previously announced, a jury in the United States District Court for the Southern District of California The United States District Court for the Southern District of California is the federal district court whose jurisdiction comprises the following counties in California: Imperial and San Diego. , a first instance court, has entered a verdict for damages against certain companies within the Elekta Group (STHLM STHLM Stockholm :EKTA.B) based on a finding of patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. .

The judge has now entered a judgment in an amount of approximately USD USD

In currencies, this is the abbreviation for the U.S. Dollar.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 25 M including damages, attorney's fees and other costs.

Elekta does not consider itself liable for any patent infringement and is of the opinion that the judgment is incorrect. Elekta intends to vigorously defend itself and protect shareholder value with all appropriate legal means and will appeal the judgment to the appellate court. Elekta's opinion, supported by legal counsel in the case, is that an appeal has a strong basis.

Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery neurosurgery /neu·ro·sur·gery/ (noor´o-sur?jer-e) surgery of the nervous system.

neu·ro·sur·ger·y
n.
Surgery on any part of the nervous system.
 solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.

More information about Elekta can be found at: www.elekta.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 12, 2002
Words:186
Previous Article:Mike Ziegler Named President of Airgas Great Lakes.
Next Article:Whole Living's Subsidiary Sets 7th Consecutive Revenue Increase.



Related Articles
Elekta Receives Jury Ruling in U.S. Patent Dispute.
Elekta AB -publ- Interim Report for the Nine Months Ended January 31, 2002.
ELEKTA AB -- publ -- Report on Operations for the Fiscal Year Ended April 30, 2002.
Elekta's Patent Dispute in the U.S.
Elekta AB : Interim Report for the Three-Months Ended July 31, 2002.
Elekta's Annual General Meeting 2002.
ELEKTA AB: Interim Report for the Six-Month Period May 1 Through October 31, 2002.
Elekta Comments on Decision by Stockholmsborsen's Disciplinary Committee.
Elekta AB -publ- Nine Months Report Ended January 2003.
SEOUL HOSPITAL SELECTS ELEKTA MEG EQUIPMENT.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles